Palantir is a strong buy with booming AI platforms, 29% revenue growth, and strategic positioning in the AI arms race. Click ...

MSCI's asset-light business model, high client switching costs, and minimal tariff impact make it a preferred investment ...

Metro has been outperforming the market during these volatile times, and its Q2 results were relatively strong. Find out why ...

At a market cap of 4.7B EUR and EV/EBITDA of 4.8, Arkema is attractively priced, even with a potential 15% EBITDA reduction.

When markets move, we can learn a lot from the outperformers. But we can also learn a lot from the underperformers - and ...

KREF's Series A is attractively priced for a company with a credit rating of B+. Though current yields of near 9% exist, ...

Adriatic Metals PLC upgraded to Buy due to Vareš project ramp-up, expected commercial production in Q1 2025, and favorable ...

Rocket Lab's heavy reliance on government contracts makes it especially vulnerable to cost-cutting in this sector. Check out ...

VitalHub, a healthcare software provider, has seen an 18% drop since January 2025 despite a 30% revenue growth during FY2024.

Geopolitical tensions are impacting markets, from luxury to gold. Read here for strategies to hedge wisely, spot ...

OPTZ, a unique all-cap ETF with GARP features. Low 14.77x P/E and high-growth potential, but higher risk. See more on OPTZ ...

Fidelity National Information Services, Inc. and Global Payments Inc. reshuffle positions with $37.75B deals. Click for ...